Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fortress Biotech, Inc. - Common Stock (NQ:FBIO)

3.360 -0.540 (-13.85%)
Streaming Delayed Price Updated: 1:29 PM EST, Jan 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fortress Biotech, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
FBIO Stock Surges 12% Pre-Market After It Wins FDA Approval For Rare Pediatric Menkes Disease ↗
FDA’s ZYCUBO approval also includes a Rare Pediatric Disease Priority Review Voucher, which will be transferred to Cyprium. 
Via Stocktwits
News headline image
Which stocks are moving on Wednesday? ↗
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
Why Is Fortress Biotech Stock Falling Today? ↗
Via Stocktwits
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
News headline image
Fortress Biotech Shares Plummet as FDA Issues Complete Response Letter for Key Drug
Fortress Biotech (NASDAQ: FBIO) saw its stock plunge over 30% on October 1, 2025, following the U.S. Food and Drug Administration's (FDA) issuance of a Complete Response Letter (CRL) for its New Drug... 
Via MarketMinute
News headline image
Which stocks are moving before the opening bell on Wednesday? ↗
As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
News headline image
Cal-Maine Foods Posts Downbeat Earnings, Joins Enanta Pharmaceuticals, AAR And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Ryvyl Shares Are Trading Higher By 97%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Why Docusign Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
These stocks are moving in today's pre-market session ↗
Discover the top movers in Monday's pre-market session and stay informed about market dynamics. 
Via Chartmill
News headline image
India-Based Sun Pharma To Buy US Cancer Firm Checkpoint Therapeutics: Details ↗
Sun Pharma to acquire Checkpoint Therapeutics for $4.10 per share, with potential CVR. FDA approves Unloxcyt, the first PD-L1 blocker for advanced cSCC. 
Via Benzinga
News headline image
Why Fortress Biotech (FBIO) Stock Is Getting Hammered ↗
Fortress Biotech shares are trading lower by 20% Friday afternoon. The company announced the pricing of a $8 million registered direct offering and concurrent private placements. 
Via Benzinga
News headline image
FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q2 2024 ↗
FBIO stock results show that Fortress Biotech beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Around $10M Bet On This Tech & Telecom Stock? Check Out These 3 Stocks Insiders Are Buying ↗
 
Via Benzinga
News headline image
Insiders Buying Fortress Biotech And 2 Other Stocks ↗
 
Via Benzinga
News headline image
Greenbrier, Fortress Biotech And 3 Stocks To Watch Heading Into Monday ↗
 
Via Benzinga
News headline image
Why Is Penny Stock Mustang Bio Trading Over 190% On Monday? ↗
Mustang Bio shares soar 190.9% on high trading volume as Phase 1/2 trial data for CAR T-cell therapy MB-106 shows positive results. 
Via Benzinga
News headline image
FBIO Stock Earnings: Fortress Biotech Beats EPS, Misses Revenue for Q1 2024 ↗
FBIO stock results show that Fortress Biotech beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024 ↗
Biotech stocks can offer some of the most explosive, exciting opportunities on the market.That is, if you find the right one. 
Via InvestorPlace
News headline image
FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q4 2023 ↗
FBIO stock results show that Fortress Biotech beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries
Via Get News
Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries
--News Direct-- 
Via News Direct
Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries
New York, Feb 2, 2024 - (Plato Data via 500NewsWire) -- Fortress Biotech (Fortress Bio), a unique biotech company led by industry veteran Dr. Lindsay Rosenwald, focused on identifying, in-licensing and... 
Via TheNewswire.com
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.